KR102384118B9 - Compositions for preventing or treating macular degeneration - Google Patents

Compositions for preventing or treating macular degeneration

Info

Publication number
KR102384118B9
KR102384118B9 KR1020210109492A KR20210109492A KR102384118B9 KR 102384118 B9 KR102384118 B9 KR 102384118B9 KR 1020210109492 A KR1020210109492 A KR 1020210109492A KR 20210109492 A KR20210109492 A KR 20210109492A KR 102384118 B9 KR102384118 B9 KR 102384118B9
Authority
KR
South Korea
Prior art keywords
compositions
preventing
macular degeneration
treating macular
treating
Prior art date
Application number
KR1020210109492A
Other languages
Korean (ko)
Other versions
KR20210106942A (en
KR102384118B1 (en
Inventor
박동호
이인규
Original Assignee
경북대학교 산학협력단
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1020190136771A external-priority patent/KR102294439B1/en
Application filed by 경북대학교 산학협력단 filed Critical 경북대학교 산학협력단
Publication of KR20210106942A publication Critical patent/KR20210106942A/en
Application granted granted Critical
Publication of KR102384118B1 publication Critical patent/KR102384118B1/en
Publication of KR102384118B9 publication Critical patent/KR102384118B9/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
KR1020210109492A 2018-11-02 2021-08-19 Compositions for preventing or treating macular degeneration KR102384118B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR1020180133677 2018-11-02
KR20180133677 2018-11-02
KR1020190136771A KR102294439B1 (en) 2018-11-02 2019-10-30 Compositions for preventing or treating macular degeneration

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR1020190136771A Division KR102294439B1 (en) 2018-11-02 2019-10-30 Compositions for preventing or treating macular degeneration

Publications (3)

Publication Number Publication Date
KR20210106942A KR20210106942A (en) 2021-08-31
KR102384118B1 KR102384118B1 (en) 2022-04-08
KR102384118B9 true KR102384118B9 (en) 2022-07-06

Family

ID=70462647

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020210109492A KR102384118B1 (en) 2018-11-02 2021-08-19 Compositions for preventing or treating macular degeneration

Country Status (3)

Country Link
JP (2) JP7280353B2 (en)
KR (1) KR102384118B1 (en)
WO (1) WO2020091430A1 (en)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005037990A2 (en) * 2003-05-29 2005-04-28 Albert Einstein College Of Medecine Of Yeshiva University Use of parp inhibitors for prevention and treatment of diabetic and insulin resistance complications
KR20100008548A (en) * 2008-07-16 2010-01-26 (주) 서울바이오메드 A composition for treatment of choroidal neovascular diseases comprising chlorogenic acid
KR101706389B1 (en) * 2010-10-21 2017-02-14 경희대학교 산학협력단 Composition for inhibiting angiogenesis, VEGF or HIF1-alpha
EP3096617A4 (en) * 2014-01-23 2017-09-13 Akebia Therapeutics Inc. Compositions and methods for treating ocular diseases
JP6585060B2 (en) * 2014-08-29 2019-10-02 株式会社レナサイエンス Pharmaceutical composition comprising a combination of a pyridoxamine compound and a thiamine compound
KR20180133677A (en) 2017-06-07 2018-12-17 최정빈 Mountable mobile phone case with lens storage container

Also Published As

Publication number Publication date
JP2023062085A (en) 2023-05-02
WO2020091430A1 (en) 2020-05-07
KR20210106942A (en) 2021-08-31
JP7280353B2 (en) 2023-05-23
JP2022504098A (en) 2022-01-13
KR102384118B1 (en) 2022-04-08

Similar Documents

Publication Publication Date Title
EP3697920A4 (en) Compositions and methods for treating age-related macular degeneration
ZA202101362B (en) Compositions and methods for treating the eye
EP3609528A4 (en) Compositions for treating addiction
IL285886A (en) Compositions and methods for treating laminopathies
IL277779A (en) Compositions and methods for treating macular dystrophy
IL247116B (en) Compositions and methods for treating and preventing macular degeneration
SG11202012055PA (en) Methods and compositions for preventing or treating calciphylaxis
ZA202101342B (en) Compositions and methods for treating the eye
ZA201907973B (en) Agent for preventing or treating brain atrophy
EP3672579A4 (en) Compositions and methods for treating age-related macular degeneration and geographic atrophy
ZA201904051B (en) Peptide for treating age-related macular degeneration
IL285796A (en) Methods and compositions for treating
ZA201907238B (en) Compositions for treating neurodegenerative diseases
IL277463A (en) Compositions and methods for treating pruritus
ZA202101361B (en) Compositions and methods for treating the eye
ZA202101360B (en) Compositions and methods for treating the eye
ZA202007183B (en) Compositions and methods for treating the eye
EP3526249A4 (en) Compositions and methods for treating and preventing transplant-associated injury
EP3892286A4 (en) Pharmaceutical composition containing aucuba japonica extract for preventing or treating macular degeneration
PT3810128T (en) Compositions for treating and/or preventing protein-aggregation diseases
EP3661492A4 (en) Methods and compositions for treating neurological conditions
EP3875092A4 (en) Composition for prevention or treatment of macular degeneration
KR102384118B9 (en) Compositions for preventing or treating macular degeneration
EP3732179A4 (en) Compounds and compositions for treating fibrosis
EP3727382A4 (en) Compositions and methods for preventing and treating conditions

Legal Events

Date Code Title Description
A107 Divisional application of patent
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
G170 Re-publication after modification of scope of protection [patent]